You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Islet & Pancreas Transplant Articles
Popular Islet & Pancreas Transplant Articles
Highly Recommended Islet & Pancreas Transplant Articles
Send a link to this page to your friends and colleagues.
According to a recent poll by the Juvenile Diabetes Research Foundation International (JDRF), twice as many Americans support federal funding of stem cell research than oppose it.
In the poll, which was conducted in January by the Opinion Research Corporation International, 65 percent of the 1,004 respondents said they support federal funding, while 26 percent opposed it. The remaining nine percent were undecided.
Prior to asking the question, respondents were educated on how the use of stem cells from human embryos may be beneficial in developing cures for diabetes, as well as a host of other diseases.
According to the poll, men are more likely than women to be in favor of the funding (68 percent to 63 percent). Results also showed that Americans with at least a high school diploma are more likely to favor it than those without one (68 to 61 percent).
According to a recent online news poll conducted on the DIABETES HEALTH Web site, 78 percent of respondents support using stem cells, saying it may "help advance cures for diabetes and other diseases." Fifteen percent said they oppose the use of embryonic stem cells, agreeing that it "cheapens human life and is wrong." Eight percent of those polled feel there needs to be more research proving stem cells from human embryos work before developing an opinion.
0 comments - Mar 1, 2001
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.